Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 25
Filtrer
1.
Pulm Circ ; 12(2): e12086, 2022 Apr.
Article de Anglais | MEDLINE | ID: mdl-35685948

RÉSUMÉ

Whereas younger female patients were diagnosed with idiopathic pulmonary arterial hypertension (IPAH) in 1980s, it is now frequently encountered in elderly patients with cardiovascular comorbidities (CVCs) associated with increased risk for left heart disease. We present data until November 2019 regarding specific features and clinical outcomes of IPAH population from the Hellenic Pulmonary Hypertension Registry (HOPE). Patients were divided into two groups based on the presence of ≥ or <3 CVCs, arterial hypertension, diabetes mellitus, obesity, presence of coronary artery disease, or atrial fibrillation. Overall, 77 patients with IPAH (55.1 [interquartile range, IQR: 24.1] years, 62.8% women) have been recorded. Fifteen patients (19.2%) had ≥3 CVCs, while 25 (32%) were over 65 years old. Patients with ≥3 CVCs were older, presented an almost equal female to male ratio, walked less in 6-min walk test, and had lower mean arterial pulmonary pressure and pulmonary vascular resistance at baseline than patients with less CVCs. Fewer patients with ≥3 CVCs received PAH-specific treatment compared to patients with less comorbidities (n = 11 [73.3%] versus n = 58 [95.5%], p = 0.02). During a median follow-up period of 3.8 (IQR: 2.7) years, 18 patients died (all-cause mortality 24.3%). Male sex and older age were independent predictors of mortality and/or lung transplantation, while CVCs did not have a significant impact on clinical outcomes. In this nationwide, register-based study, the epidemiology of IPAH involves older patients with CVCs, who seem to have less hemodynamic compromise, but worse functional impairment and are treated less aggressively with PAH pharmacotherapy.

3.
Am J Cardiol ; 126: 89-93, 2020 07 01.
Article de Anglais | MEDLINE | ID: mdl-32345471

RÉSUMÉ

Pericardial effusion (PE) prognosis depends on the underlying etiology. We sought to assess the outcome of patients with chronic (>3 months), large (diastolic echo-free space >2 cm), idiopathic (without apparent etiology), C-reactive protein (CRP) negative PE, a topic where data are lacking. A total of n = 74 patients were enrolled in this study. Patients were treated by pericardiocentesis (n = 39) or surgical pericardial "window" (PW) (n = 13) or conservatively (n = 22). The median follow-up was 24 months (interquartile range: 15 to 38). Among those patients who had PE drained (n = 52), PE re-accumulation occurred in 32 cases (61.5%) and the rate was significantly higher in the pericardiocentesis subgroup (76.9% for pericardiocentesis vs 15.4% for PW group, p <0.001). Patients with re-accumulation had longer disease duration (32.1 ± 25.7 months vs 19.5 ± 23.8 months, p = 0.01), higher maximum PE diameter (32.2 ± 9.4 mm vs 26.1 ± 4.9 mm, p = 0.003) and larger PE volume drained at baseline (1,912 ± 707 mL vs 1,508 ± 387 mL, p = 0.04). Large PE re-accumulation occurred in 41% of patients who underwent pericardiocentesis and in 7.7% of those who underwent PW. In Cox survival analysis the only independent predictor of fluid re-accumulation was the type of intervention, with PW being associated with significantly reduced risk (hazard ratio 0.115, 95% confidence interval 0.015 to 0.875, p = 0.037). Major complications needing treatment were recorded in 12.8% and 15.4% (p = 0.999) of patients who underwent pericardiocentesis and PW, respectively. Moreover, invasive procedures were not helpful in establishing new diagnoses and guide treatment. In conclusion, in asymptomatic patients with chronic, large, hemodynamically insignificant, CRP negative, idiopathic PE, conservative management seems a more reasonable approach in most cases.


Sujet(s)
Traitement conservateur , Épanchement péricardique/thérapie , Techniques de fenêtre péricardique , Péricardiocentèse , Sujet âgé , Maladies asymptomatiques , Femelle , Études de suivi , Humains , Mâle , Adulte d'âge moyen , Études prospectives , Récidive
4.
Pulm Circ ; 9(3): 2045894019877157, 2019.
Article de Anglais | MEDLINE | ID: mdl-31662847

RÉSUMÉ

Pulmonary arterial hypertension (PAH) is a heterogenous clinical entity with poor prognosis, despite recent major pharmacological advances. To increase awareness about the pathophysiology, epidemiology, and management of the disease, large national registries are required. The Hellenic pulmOnary hyPertension rEgistry (HOPE) was launched in early 2015 and enrolls patients from all pulmonary hypertension subgroups in Greece. Baseline epidemiologic, diagnostic, and initial treatment data of consecutive patients with PAH are presented in this article. In total, 231 patients with PAH were enrolled from January 2015 until April 2018. At baseline, about half of patients with PAH were in World Health Organization functional class II. The majority of patients with PAH (56.7%) were at intermediate 1-year mortality risk, while more than one-third were low-risk patients, according to an abbreviated risk stratification score. Half of patients with PAH were on monotherapy, 38.9% received combination therapy, while prostanoids were used only in 12.1% of patients. In conclusion, baseline data of the Greek PAH population share common characteristics, but also have some differences with other registries, the most prominent being a better functional capacity. This may reflect earlier diagnosis of PAH that in conjunction with the increased proportion of patients with atypical PAH could partially explain the preference for monotherapy and the limited use of prostanoids in Greece. Nevertheless, early, advanced specific therapy is strongly recommended.

5.
Heart ; 105(6): 465-469, 2019 03.
Article de Anglais | MEDLINE | ID: mdl-30269081

RÉSUMÉ

OBJECTIVE: Despite the progress in the management of patients with adult congenital heart disease (ACHD), a significant proportion of patients still develop pulmonary hypertension (PH). We aimed to highlight the rate of the complications in PH-ACHD and the predicting factors of cumulative mortality risk in this population. METHODS: Data were obtained from the cohort of the national registry of ACHD in Greece from February 2012 until January 2018. RESULTS: Overall, 65 patients receiving PH-specific therapy were included (mean age 46.1±14.4 years, 64.6% females). Heavily symptomatic (New York Heart Association (NYHA) class III/IV) were 53.8% of patients. The majority received monotherapy, while combination therapy was administered in 41.5% of patients. Cardiac arrhythmia was reported in 30.8%, endocarditis in 1.5%, stroke in 4.6%, pulmonary arterial thrombosis in 6.2%, haemoptysis in 3.1% and hospitalisation due to heart failure (HF) in 23.1%. Over a median follow-up of 3 years (range 1-6), 12 (18.5%) patients died. On univariate Cox regression analysis history of HF hospitalisation emerged as a strong predictor of mortality (HR 8.91, 95% CI 2.64 to 30.02, p<0.001), which remained significant after adjustment for age and for NYHA functional class. CONCLUSIONS: Long-term complications are common among patients with PH-ACHD. Hospitalisations for HF predict mortality and should be considered in the risk stratification of this population.


Sujet(s)
Troubles du rythme cardiaque , Agents cardiovasculaires/usage thérapeutique , Cardiopathies congénitales , Défaillance cardiaque , Hospitalisation/statistiques et données numériques , Hypertension pulmonaire , Accident vasculaire cérébral , Adulte , Troubles du rythme cardiaque/épidémiologie , Troubles du rythme cardiaque/étiologie , Troubles du rythme cardiaque/thérapie , Femelle , Études de suivi , Grèce/épidémiologie , Cardiopathies congénitales/complications , Cardiopathies congénitales/mortalité , Défaillance cardiaque/épidémiologie , Défaillance cardiaque/étiologie , Défaillance cardiaque/thérapie , Humains , Hypertension pulmonaire/diagnostic , Hypertension pulmonaire/étiologie , Hypertension pulmonaire/mortalité , Hypertension pulmonaire/thérapie , Mâle , Adulte d'âge moyen , Mortalité , Pronostic , Enregistrements/statistiques et données numériques , Appréciation des risques , Accident vasculaire cérébral/épidémiologie , Accident vasculaire cérébral/étiologie , Accident vasculaire cérébral/thérapie
6.
Eur J Cardiothorac Surg ; 52(6): 1229-1230, 2017 Dec 01.
Article de Anglais | MEDLINE | ID: mdl-28977412

RÉSUMÉ

Transcatheter aortic valve replacement has emerged as an alternative to surgical aortic valve replacement for high-risk and inoperable patients. Although transcatheter aortic valve replacement avoids the use of extracorporeal circulation and sternotomy, it is nonetheless associated with inherent complications. We aim to present an embolized valve-in-valve complex in the ascending aorta, which required emergency surgery with deep hypothermic circulatory arrest and proximal aortic cannulation.


Sujet(s)
Aorte/chirurgie , Sténose aortique/thérapie , Valve aortique/chirurgie , Embolisation thérapeutique/méthodes , Prothèse valvulaire cardiaque , Remplacement valvulaire aortique par cathéter/méthodes , Valve aortique/imagerie diagnostique , Sténose aortique/diagnostic , Humains , Mâle , Tomodensitométrie
7.
J Clin Lab Anal ; 30(3): 204-7, 2016 May.
Article de Anglais | MEDLINE | ID: mdl-25716092

RÉSUMÉ

BACKGROUND: Androgens are known to influence the risk of developing cardiovascular diseases. This study aims at investigating the possible association between G1733A polymorphism in the coding region of androgen receptor (AR) gene and premature coronary artery disease (CAD). METHODS: A total of 460 Greek subjects were investigated for the G1733A polymorphism. The patient group consisted of 250 CAD individuals, aged less than 58 years, while 210 healthy individuals served as controls. Genotyping was performed using the PCR-RFLP method. RESULTS: Significant differences in genotype distribution (P = 0.0067) and allele frequencies (P = 0.0060) have been observed between patients and controls in the women's subgroup. Conversely, the genotype/allele frequencies were similar between patients and controls in the subgroup of men. CONCLUSION: We may conclude that the G1733A polymorphism of AR gene could be a useful genetic marker for the assessment of a woman's risk for CAD in our Caucasian Greek population.


Sujet(s)
Maladie des artères coronaires/génétique , Prédisposition génétique à une maladie , Polymorphisme de nucléotide simple/génétique , Récepteurs aux androgènes/génétique , Caractères sexuels , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Études cas-témoins , Femelle , Fréquence d'allèle/génétique , Humains , Mâle , Adulte d'âge moyen , Facteurs de risque
8.
Gen Thorac Cardiovasc Surg ; 64(10): 621-4, 2016 Oct.
Article de Anglais | MEDLINE | ID: mdl-25851545

RÉSUMÉ

Dual aortic and ventricular thrombi are rare following myocardial infraction. We report the case of a 56-year-old man who initially denied primary percutaneous coronary intervention as a result of psychological phobia. Initial pharmacological management by thrombolysis and heparin was followed by multiple arterial thromboses including those of the left ventricle and right iliac artery with a subsequent diagnosis of heparin-induced thrombocytopaenia. Ensuing surgical management revealed the unanticipated finding of an additional aortic sinus thrombosis that was excised. The left ventricular thrombus was removed endoscopically to prevent ventricular incisions. This case emphasizes the technical advantages of video-endoscopic management of intracardiac thrombi and highlights the unexpected nature of multiple thromboses associated with heparin-induced thrombocytopaenia.


Sujet(s)
Anticoagulants/effets indésirables , Cardiopathies/chirurgie , Sinus de l'aorte , Thrombectomie/méthodes , Thrombopénie/complications , Thrombose/chirurgie , Échocardiographie/méthodes , Ventricules cardiaques , Héparine/effets indésirables , Humains , Mâle , Adulte d'âge moyen , Intervention coronarienne percutanée , Chirurgie thoracique vidéoassistée/méthodes , Thrombopénie/induit chimiquement , Thrombose/diagnostic
9.
Angiology ; 67(1): 66-74, 2016 Jan.
Article de Anglais | MEDLINE | ID: mdl-25818103

RÉSUMÉ

UNLABELLED: The aim of this study was to evaluate the gender-oriented differences in the outcomes of a lifestyle intervention trial (diet, smoking cessation, and exercise) among patients who had open heart surgery. A randomized, nonblind intervention study was performed on 500 patients who had open heart surgery. Immediately after hospital discharge, 250 patients were randomly allocated lifestyle intervention by receiving oral and written information in the form of a booklet with specific educational information for postoperative rehabilitation. The remaining 250 patients received the regular oral instructions. The applied lifestyle intervention proved to be beneficial only in men as far as quitting smoking (relative risk [RR]: 0.36, confidence interval [CI]: 0.16-0.80; P = .01) and returning to work (RR: 0.35, CI: 0.13-0.92; P = .03) are concerned. For both genders, no significant associations between dietary and physical activity recommendations were observed. CONCLUSION: Lifestyle nursing intervention immediately after open heart surgery had a beneficial effect on men 1 year after the surgery but not on women. Thus, there is a need for gender-specific studies among women.


Sujet(s)
Procédures de chirurgie cardiaque , Comportement en matière de santé , Cardiopathies/rééducation et réadaptation , Mode de vie , Activité motrice , Arrêter de fumer/méthodes , Sujet âgé , Femelle , Cardiopathies/chirurgie , Humains , Mâle , Adulte d'âge moyen , Éducation du patient comme sujet , Période postopératoire , Pronostic , Facteurs sexuels
10.
J Clin Nurs ; 24(11-12): 1611-21, 2015 Jun.
Article de Anglais | MEDLINE | ID: mdl-25727522

RÉSUMÉ

AIMS AND OBJECTIVES: To evaluate the one-year prognosis of a lifestyle counselling intervention (diet, smoking cessation and exercise) among patients who had open heart surgery. BACKGROUND: Cardiovascular disease is the leading cause of morbidity worldwide in both developing and developed countries. Lifestyle modification plays an important role for patients who are at a high risk of developing cardiovascular disease and for those with an established cardiovascular disease. DESIGN: Randomised, nonblind and lifestyle counselling intervention study with a one-year follow-up. METHODS: A randomised, nonblind intervention study was performed on 500 patients who had open heart surgery. After hospital discharge, 250 patients (intervention group) were randomly allocated lifestyle counselling according to the recent guidelines provided by the European Society of Cardiology (European Journal Preventive Cardiology, 19, 2012, 585). The remaining 250 patients (control group) received the regular instructions. Primary end-point was the development of a cardiovascular disease (nonfatal event) during the first year; secondary end-points included fatal events, smoking abstinence, dietary habits and a physical activity evaluation. RESULTS: According to the primary end-point, the odds of having a nonfatal cardiovascular disease event are 0·56-times (95%CI 0·28, 0·96, p = 0·03) lower for the intervention group compared to the control group. One-year after surgery, it was found that participants in the intervention group were 1·96-times (95%CI 1·31, 2·93, p < 0·001) more likely to achieve dietary recommendations, 3·32-times (95%CI 2·24, 4·91, p < 0·001) more likely to achieve physical activity recommendations and 1·34-times (95%CI 1·15, 1·56, p < 0·001) more likely to return to work. CONCLUSION: Lifestyle counselling intervention following open heart surgery can improve health outcomes and reduce the risk of a new cardiac event. Health care services must recommend and organise well-structured cardiac rehabilitation programmes adjusted to the patient's needs. RELEVANCE TO CLINICAL PRACTICE: A well-structured cardiac rehabilitation programme adjusted to the patient's profile is a safe and cost-effective way to improve patients' outcome.


Sujet(s)
Assistance , Mode de vie , Infarctus du myocarde/soins infirmiers , Sujet âgé , Procédures de chirurgie cardiaque/statistiques et données numériques , Régime alimentaire , Exercice physique , Femelle , Grèce , Humains , Mâle , Adulte d'âge moyen , Infarctus du myocarde/rééducation et réadaptation , Infarctus du myocarde/chirurgie , Période postopératoire , Pronostic , Arrêter de fumer , Résultat thérapeutique
11.
Hellenic J Cardiol ; 55(2): 126-31, 2014.
Article de Anglais | MEDLINE | ID: mdl-24681790

RÉSUMÉ

INTRODUCTION: Sex hormones are well known to increase the risk of coronary artery disease (CAD). The CYP17 gene encodes the enzyme cytochrome P450c17, which functions at key steps during the process of human sex steroid hormone synthesis. A T/C polymorphism in the 5 promoter region of the CYP17 gene influences its expression and the resulting serum levels of androgens and estrogens. The aim of this casecontrol study was to investigate the role of a T/C CYP17 polymorphism in premature CAD and the occurrence of myocardial infarction (MI) in the Caucasian Greek population. METHODS: Our study group consisted of 230 CAD patients, aged less than 58 years, while 200 healthy individuals served as controls. The genotyping of the T/C CYP17 polymorphism was carried out using the PCRRFLP method. RESULTS: The frequencies of TT, TC, and CC genotypes were 0.38, 0.42, and 0.20, respectively, in the patient group, and 0.35, 0.44, and 0.21, respectively, in the control group. Allele frequencies for the patient group were 0.58 and 0.42 for T and C, respectively, and 0.57 and 0.43, respectively, for the control group. Statistical analysis revealed no significant differences between patients and controls in genotype frequencies (p=0.8746) or allele frequencies (p=0.6783). CONCLUSIONS: These findings do not support the hypothesis that the genetic variation T/C of the promoter of the CYP17 gene is an important contributing factor in the aetiology of premature CAD or occurrence of MI in the Caucasian Greek population.


Sujet(s)
Maladie des artères coronaires , Infarctus du myocarde , Steroid 17-alpha-hydroxylase/génétique , Adulte , Âge de début , Maladie des artères coronaires/épidémiologie , Maladie des artères coronaires/génétique , Femelle , Hormones sexuelles stéroïdiennes/biosynthèse , Hormones sexuelles stéroïdiennes/génétique , Grèce/épidémiologie , Humains , Mâle , Adulte d'âge moyen , Infarctus du myocarde/épidémiologie , Infarctus du myocarde/génétique , Polymorphisme génétique , Facteurs de risque
12.
J Heart Lung Transplant ; 31(8): 881-7, 2012 Aug.
Article de Anglais | MEDLINE | ID: mdl-22503846

RÉSUMÉ

BACKGROUND: Connective tissue growth factor (CTGF) has been reported to be upregulated in experimental models of chronic cardiac allograft rejection. We investigated the contribution of CTGF to the development of cardiac allograft vasculopathy (CAV), a surrogate marker for chronic rejection. METHODS: This prospective study included 72 adult heart allograft recipients. Genotyping of the rs6918698 polymorphism was performed by sequence-specific primer polymerase chain reaction (PCR). CTGF protein levels were measured in serum. CTGF messenger RNA (mRNA) from myocardial biopsy specimens was quantified by quantitative real-time PCR. RESULTS: Recipient genotype was associated with the development of CAV (p = 0.014) and the carriers of the C allele (CC and CG genotype) were high-risk recipients for the development of CAV (odds ratio, 3.30; 95% confidence interval, 1.12-9.74; p = 0.044). Serum CTGF protein levels could not be associated with the presence of the C allele but were significantly lower in the patients that had developed CAV (p = 0.038). This was attributed to the addition of everolimus to their immunosuppression scheme. Myocardial relative CTGF mRNA expression was estimated to be approximately twice as much in the CAV patients than in the patients without CAV (p = 0.013). CONCLUSIONS: The important role of CTGF during the development of CAV in heart transplantation was supported by the association of CAV with the recipient CTGF-945 CC/CG genotypes. The CAV patients, who were all receiving everolimus treatment, displayed elevated myocardial CTGF mRNA transcription levels, while everolimus has been observed to reduce serum CTGF protein levels.


Sujet(s)
Facteur de croissance du tissu conjonctif/génétique , Facteur de croissance du tissu conjonctif/physiologie , Rejet du greffon/étiologie , Transplantation cardiaque , Maladies vasculaires/génétique , Maladies vasculaires/physiopathologie , Adolescent , Adulte , Marqueurs biologiques/métabolisme , Biopsie , Évérolimus , Femelle , Études de suivi , Génotype , Rejet du greffon/immunologie , Rejet du greffon/prévention et contrôle , Transplantation cardiaque/immunologie , Transplantation cardiaque/anatomopathologie , Humains , Immunosuppresseurs/usage thérapeutique , Mâle , Adulte d'âge moyen , Myocarde/métabolisme , Myocarde/anatomopathologie , Polymorphisme génétique/génétique , Études prospectives , ARN/métabolisme , Sirolimus/analogues et dérivés , Sirolimus/usage thérapeutique , Transplantation homologue , Maladies vasculaires/complications , Jeune adulte
13.
Ann Nucl Med ; 26(3): 228-33, 2012 Apr.
Article de Anglais | MEDLINE | ID: mdl-22222778

RÉSUMÉ

AIM: The precise localization of bone marrow stem cells (SCs) into the necrotic tissue after intracoronary infusion (ICI) may be important for the therapeutic outcome. This study aims to examine the correlation between Tl-201 and Tc-99m-hexa-methyl-propylene-amine-oxime (HMPAO) images. METHODS: Thirteen patients, aged 36-62 years, with an old, nonviable, anterior myocardial infarction (MI) and reduced myocardial contractility (LVEF <40%), underwent ICI of selected CD133(+) and CD133(neg)CD34(+) SCs. One hour after the ICI, SPECT imaging with Tc-99m-HMPAO was performed in all patients and the acquired images were compared with the images obtained during the initial imaging for demonstration of viability (myocardial perfusion imaging with pharmacologic stress and Tl-201). Furthermore, two fused bull's eye images of Tc-99m-HMPAO and Tl-201 rest reinjection were created in six patients and regions of interest were set on Tl-201 and Tc-99m-HMPAO bull's eye images. RESULTS: The comparison of the two sets of images revealed an intense accumulation of the SCs in the infarcted area with absence of viability as assessed by Tl-201 reinjection images. In the subset of patients in whom fused bull's eye images were produced, the comparison demonstrated that the percentage of the infarcted area with SCs' adherence was 83.2 ± 17%. CONCLUSIONS: Tl-201 images are complementary with the respective Tc-99m-HMPAO ones, revealing a precise localization of SCs in the infarcted area. Tc-99m-HMPAO labeling of SCs is a reliable method for cell monitoring after ICI in nonviable myocardium after an anterior MI.


Sujet(s)
Cellules de la moelle osseuse/anatomopathologie , Infarctus du myocarde/imagerie diagnostique , Infarctus du myocarde/anatomopathologie , Scintigraphie/méthodes , Cellules souches/anatomopathologie , Examétazime de technétium (99mTc) , Radio-isotopes du thallium , Adulte , Adhérence cellulaire , Femelle , Humains , Mâle , Adulte d'âge moyen , Myocarde/anatomopathologie , Nécrose , Études rétrospectives , Cellules souches/imagerie diagnostique , Facteurs temps
14.
Hellenic J Cardiol ; 52(1): 15-22, 2011.
Article de Anglais | MEDLINE | ID: mdl-21292603

RÉSUMÉ

INTRODUCTION: In this prospective, single-center study we assessed the long-term results after drug-eluting stent implantation in non insulin-dependent diabetic patients compared to insulin-dependent patients. METHODS: A total of 610 consecutive diabetic patients (mean age 65 ± 9 years) underwent percutaneous coronary intervention with drug-eluting stent implantation. They were classified into 2 groups according to their diabetic treatment: 1) non insulin-dependent patients (477); 2) insulin-dependent patients (133). The primary endpoint was the composite of death, non-fatal myocardial infarction, bypass surgery and target lesion revascularization. RESULTS: Clinical follow up for more than 12 months (median 29 months) was achieved in 597/610 patients (98%). The insulin-dependent group had more women (29% vs. 18%, p=0.003), as well as a higher incidence of multivessel disease (84% vs. 65%, p<0.0001) and ejection fraction <40% (16% vs. 9%, p=0.037) compared to the non insulin-dependent group. The in-hospital results were almost the same in both groups, except for the incidence of non-Q myocardial infarction and bleeding complications, which were more frequent in the insulin-dependent group (9.8% vs. 4.8%, p=0.03, and 1.5% vs. 0%, p=0.047, respectively). During clinical follow up, no significant differences in the incidence of death or non-fatal myocardial infarction were observed, but target lesion revascularization and bypass surgery were more frequent in the insulin-dependent group (8.5% vs. 3.4%, p=0.01, and 4.7% vs. 1.3%, p=0.01, respectively). The event-free survival was lower in the insulin-dependent group (hazard ratio: 0.52; 95% confidence interval, 0.31-0.85, p=0.01). CONCLUSION: The implantation of drug-eluting stents in diabetics is associated with excellent in-hospital and long-term results. However, the long-term effectiveness in insulin-dependent patients is lower, because of the greater risk of new revascularization.


Sujet(s)
Angioplastie coronaire par ballonnet , Maladie coronarienne/thérapie , Diabète de type 1/thérapie , Diabète de type 2/thérapie , Angiopathies diabétiques/thérapie , Endoprothèses à élution de substances , Sujet âgé , Pontage aortocoronarien , Maladie coronarienne/mortalité , Resténose coronaire/épidémiologie , Resténose coronaire/prévention et contrôle , Femelle , Humains , Insulinorésistance/physiologie , Mâle , Adulte d'âge moyen , Infarctus du myocarde/prévention et contrôle , Études prospectives , Résultat thérapeutique
15.
Hellenic J Cardiol ; 50(6): 484-92, 2009.
Article de Anglais | MEDLINE | ID: mdl-19942562

RÉSUMÉ

INTRODUCTION: The aim of this study was to record the results from a modern diagnostic and therapeutic approach to patients with pulmonary arterial hypertension. METHODS: We studied the clinical characteristics and the treatment of 69 patients (50 women, 72.5%), aged 44 +/- 17 years, who were diagnosed with pulmonary hypertension (World Health Organisation categories I, IV and V). The patients' outcomes were recorded over 14 years' operation of our Pulmonary Hypertension Unit. RESULTS: Twenty-seven patients (39.1%) suffered from idiopathic pulmonary hypertension, 12 (17.4%) from thromboembolic obstructive disease, 14 (20.3%) from congenital heart diseases, 11 (15.9%) from connective tissue diseases, 3 (4.3%) from portal hypertension, 2 (2.9%) from sarcoidosis, and 1 (1.4%) from pulmonary veno-occlusive disease. Six patients (8.7%) were in New York Heart Association (NYHA) functional class I, 28 (40.6%) were in class II, 30 (43.5%) were in class III, and 5 (7.2%) were in class IV. Thirty-four patients completed a 6-minute walk test and covered a mean distance of 352 +/- 137 m. N-terminal pro-brain natriuretic peptide (NT-proBNP) levels were measured in 18 patients, with a mean value of 1665 +/- 1935 pg/ml. A vasoreactivity test in 41 patients had a positive response in 10 (24.4%). Twenty-six patients (37.7%) were treated with combination therapy, whereas 16 (23.2%) either did not comply with or were not given specific medication. The mortality over a mean follow-up period of 5 +/- 4 years was 26%, significantly lower than that reported before the introduction of new drugs. An advanced NYHA class was an independent predictor of mortality (p=0.004), while elevated NT-proBNP levels were also associated with poor survival (p=0.013). CONCLUSIONS: Pulmonary arterial hypertension is a severe disease that leads to right heart failure and death. Despite the latest advances, vigilance and continuous investigation are needed in order to achieve a prompt diagnosis and the most suitable treatment.


Sujet(s)
Hypertension pulmonaire , Adolescent , Adulte , Sujet âgé , Enfant , Femelle , Humains , Hypertension pulmonaire/diagnostic , Hypertension pulmonaire/traitement médicamenteux , Hypertension pulmonaire/physiopathologie , Mâle , Adulte d'âge moyen , Jeune adulte
16.
Am J Cardiol ; 104(6): 846-9, 2009 Sep 15.
Article de Anglais | MEDLINE | ID: mdl-19733722

RÉSUMÉ

Plasma levels of brain natriuretic peptide (BNP) have been shown to correlate to aortic stenosis severity and are predictive of symptom development and survival. They also predict postoperative outcomes after valve replacement in patients with aortic stenosis. The early evolution of N-terminal-pro-BNP (NT-pro-BNP) levels after 50 aortic balloon valvuloplasty procedures performed in 45 patients was investigated. The mean NT-pro-BNP concentration decreased from 7,048 +/- 7,636 pg/ml at baseline to 5,309 +/- 6,150 pg/ml at 1 to 3 days after the procedure (mean difference 1,739 pg/ml, 95% confidence interval 804 to 2,675, p = 0.001). The absolute reduction in NT-pro-BNP levels correlated to the reductions in the maximum and mean transvalvular pressure gradients (on echocardiography: c = 0.57, p = 0.004, and c = 0.54, p = 0.012, respectively; invasively: c = 0.54, p = 0.025, and c = 0.39, p = 0.019). In conclusion, NT-pro-BNP levels decrease early after aortic balloon valvuloplasty in patients with severe aortic stenosis at high surgical risk.


Sujet(s)
Sténose aortique/sang , Sténose aortique/thérapie , Cathétérisme , Peptide natriurétique cérébral/sang , Fragments peptidiques/sang , Sujet âgé , Sujet âgé de 80 ans ou plus , Femelle , Humains , Mâle , Adulte d'âge moyen , Études prospectives
17.
EuroIntervention ; 4(4): 485-91, 2009 Jan.
Article de Anglais | MEDLINE | ID: mdl-19284071

RÉSUMÉ

AIMS: Despite encouraging results with drug-eluting stents (DES) reported in diabetic patients, the long-term safety is unknown because of very late stent thrombosis (VLST). We investigated the incidence, risk factors and clinical manifestations of VLST in diabetic patients treated with DES, during long-term clinical follow-up. METHODS AND RESULTS: A total of 610 consecutive diabetic patients underwent PCI with DES. Dual antiplatelet treatment (APLT) for 12 months received 93%, more than 12 months 72% and statin treatment 93% of patients. Clinical follow-up of at least 12 months post DES implantation was obtained in 597/610 (98%) patients. The incidence of VLST was 1.8%, and 1.7% of patients developed stent thrombosis (ST) up to 12 months. All patients with VLST presented with sudden cardiac death and 82% were on dual APLT at the time of the event. In a multivariate model the only predictor for VLST (HR: 20.58, 95% CI 5.17-81.90, p < 0.001) and overall ST (HR: 4.38, 95% CI 1.73-11.10, p = 0.002) was ejection fraction < 40%. CONCLUSIONS: The incidence of ST in diabetic patients undergoing PCI with DES and receiving dual APLT is low at long-term clinical follow-up. The only predictor for VLST and overall ST was depressed left ventricular systolic function.


Sujet(s)
Angioplastie coronaire par ballonnet , Maladie des artères coronaires/thérapie , Complications du diabète/thérapie , Endoprothèses à élution de substances , Thrombose/étiologie , Sujet âgé , Angioplastie coronaire par ballonnet/effets indésirables , Angioplastie coronaire par ballonnet/instrumentation , Angioplastie coronaire par ballonnet/mortalité , Maladie des artères coronaires/mortalité , Maladie des artères coronaires/physiopathologie , Mort subite cardiaque/étiologie , Complications du diabète/mortalité , Complications du diabète/physiopathologie , Survie sans rechute , Association de médicaments , Femelle , Mortalité hospitalière , Humains , Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase , Incidence , Mâle , Adulte d'âge moyen , Antiagrégants plaquettaires/usage thérapeutique , Modèles des risques proportionnels , Appréciation des risques , Facteurs de risque , Débit systolique , Thrombose/mortalité , Thrombose/physiopathologie , Facteurs temps , Résultat thérapeutique , Fonction ventriculaire gauche
18.
Eur J Endocrinol ; 157(4): 515-20, 2007 Oct.
Article de Anglais | MEDLINE | ID: mdl-17893267

RÉSUMÉ

OBJECTIVE: Previous experimental studies have provided evidence showing that changes in thyroid hormone signaling correspond to alterations in myocardial function in animal models of heart failure. The present study further explores whether thyroid hormone alterations are correlated with the functional status of the myocardium in patients with heart failure. METHODS: In this study, 37 patients with mean ejection fraction (EF%) of 26.2 (8.2) were included. Myocardial performance was assessed by echocardiography and cardiopulmonary exercise testing. Total tri-iodothyronine (T3), thyroxine, and TSH levels were measured in plasma. RESULTS: Total T3 was strongly correlated with VO2max (r = 0.78, P = 2 x 10(-8)). Furthermore, multivariate analysis revealed that total T3 was an independent predictor of VO2max (P = 0.000 005). A weaker but significant correlation was also found between total T3 and EF% (r = 0.56, P = 0.0004), systolic (r = 0.43, P = 0.009) and diastolic (r = 0.46, P = 0.004) blood pressure. CONCLUSIONS: changes in thyroid hormone were closely correlated to myocardial functional status in patients with heart failure. These data probably indicate a possible role of thyroid hormone in the pathophysiology of heart failure and confirm previous experimental reports.


Sujet(s)
Défaillance cardiaque/physiopathologie , Coeur/physiopathologie , Hormones thyroïdiennes/physiologie , Adulte , Amiodarone/pharmacologie , Antiarythmiques/pharmacologie , Antiarythmiques/usage thérapeutique , Cardiomyopathie dilatée/sang , Cardiomyopathie dilatée/complications , Cardiomyopathie dilatée/traitement médicamenteux , Cardiomyopathie dilatée/physiopathologie , Épreuve d'effort , Femelle , Volume expiratoire maximal par seconde , Défaillance cardiaque/sang , Défaillance cardiaque/étiologie , Humains , Mâle , Adulte d'âge moyen , Hormones thyroïdiennes/sang , Thyréostimuline/sang , Fonction ventriculaire gauche
19.
J Invasive Cardiol ; 17(8): 401-5, 2005 Aug.
Article de Anglais | MEDLINE | ID: mdl-16079443

RÉSUMÉ

BACKGROUND: Encouraging results with the use of the sirolimus-eluting stent (SES) have been recently presented in several multi-center trials. In the present study, the short- and mid-term clinical outcomes of the SES in everyday clinical practice of interventional cardiology were compared with a strategy using conventional bare metal stents. METHODS: In a total of 530 consecutive patients (males 86%, mean age 61 +/- 10 years) who had been treated with a SES were compared with a control group of 398 patients (males 87%, mean age 59 +/- 11 years) treated with a bare metal stent before the use of SES. In-hospital results and clinical outcomes during follow-up (11.22 +/- 3.4 versus 11.41 +/- 3.1 months) were obtained. RESULTS: Patients treated with SES had more risk factors for coronary artery disease or multivessel disease compared to those with treated bare metal stent. The clinical success rate was 99.6% in the SES group and 98.5% in the bare metal stent group (p = ns), and non-Q-wave myocardial infarction (MI) occurred in 5.7% and 4.0% of patients, respectively. The incidence of death or MI during follow-up was not different (1.1% versus 1.3% and 0.8% versus 1.8%; p = ns). Percutaneous or surgical revascularization for target lesion restenosis was required in 2.1% of patients treated with SES and in 10.1% of those with bare metal stents (p < 0.001), and the event-free survival from death, cerebrovascular accident, MI or any percutaneous or surgical revascularization was 93.13% and 83.63%, respectively (p < 0.01). CONCLUSIONS: The implantation of the SES is associated with excellent in-hospital and mid-term results, mainly because of dramatic reductions in the need for repeat revascularization, despite a higher risk factor profile and more complex lesion characteristics.


Sujet(s)
Angioplastie coronaire par ballonnet/instrumentation , Matériaux revêtus, biocompatibles , Sténose coronarienne/thérapie , Immunosuppresseurs/usage thérapeutique , Enregistrements , Sirolimus/usage thérapeutique , Endoprothèses , Angioplastie coronaire par ballonnet/statistiques et données numériques , Coronarographie , Resténose coronaire/épidémiologie , Sténose coronarienne/imagerie diagnostique , Femelle , Études de suivi , Humains , Incidence , Mâle , Adulte d'âge moyen , Études prospectives , Facteurs temps , Résultat thérapeutique , États-Unis/épidémiologie
20.
Eur J Cardiovasc Prev Rehabil ; 11(6): 489-96, 2004 Dec.
Article de Anglais | MEDLINE | ID: mdl-15580060

RÉSUMÉ

BACKGROUND: The benefits of inspiratory muscle training (IMT) in patients with chronic heart failure (CHF) have been inadequately studied. DESIGN AND METHODS: Using a prospective, age and sex-matched controlled study, we investigated 35 patients with moderate to severe CHF (NYHA class II-III and left ventricular ejection fraction 24.4+/-1.3% [mean+/-SEM]). An incremental respiratory endurance test using a fixed respiratory workload was provided by software with an electronic mouth pressure manometer interfaced with a computer. The training group (n=20) exercised at 60% of individual sustained maximal inspiratory pressure (SMIP) and the control group (n=15) at 15% of SMIP. All patients exercised three times weekly for 10 weeks. Pulmonary function, exercise capacity, dyspnea and quality of life were assessed, pre- and post-training. RESULTS: The training group significantly increased both maximum inspiratory pressure (Pimax), (111+/-6.8 versus 83+/-5.7 cmH2O, P<0.001), and SMIP (527822+/-51358 versus 367360+/-41111 cmH2O/sec x 10(-1), P<0.001). Peak VO2 increased after training (17.8+/-1.2 versus 15.4+/-0.9 ml/kg/min, P<0.005), as did the six-minute walking distance (433+/-16 versus 367+/-22 meters, P<0.001). Perceived dyspnea assessed using the Borg scale was reduced for both the treadmill (12.7+/-0.57 versus 14.2+/-0.48, P<0.005) and the walking (9+/-0.48 versus 10.5+/-0.67, P<0.005) exercise tests and the quality of life score was also improved (21.1+/-3.5 versus 25.2+/-4, P<0.01). Resting heart rate was significantly reduced with training (77+/-3.3 versus 80+/-3 beats/min, P<0.05). The control group significantly increased Pimax (86.6+/-6.3 versus 78.4+/-6.9 cmH2O, P<0.05), but decreased SMIP (274972+/-32399 versus 204661+/-37184 cmH2O/sec x 10(1), P<0.005). No other significant effect on exercise capacity, heart rate, dyspnea, or quality of life was observed in this group. CONCLUSION: Inspiratory muscle training using an incremental endurance test, successfully increases both inspiratory strength and endurance, alleviates dyspnea and improves functional status in CHF.


Sujet(s)
Exercices respiratoires , Dyspnée/rééducation et réadaptation , Épreuve d'effort , Défaillance cardiaque/rééducation et réadaptation , Endurance physique/physiologie , Dyspnée/physiopathologie , Femelle , Volume expiratoire maximal par seconde/physiologie , Défaillance cardiaque/physiopathologie , Rythme cardiaque/physiologie , Humains , Capacité inspiratoire/physiologie , Mâle , Manométrie , Adulte d'âge moyen , Consommation d'oxygène/physiologie , Études prospectives , Qualité de vie , Muscles respiratoires/physiopathologie , Débit systolique/physiologie , Résultat thérapeutique , Dysfonction ventriculaire gauche/physiopathologie , Dysfonction ventriculaire gauche/rééducation et réadaptation , Capacité vitale/physiologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE